🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, open-label, single arm, phase II study investigating the cli...
Status
Completed
Location
Universitätsklinikum Freiburg
Start Date
2022-06-14
Trial ID
NCT05393674
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of ora...
Status
Completed
Location
UCSD Moores Cancer Center
Start Date
2008-01
Trial ID
NCT00631462
Treatments Being Tested
Primary Objective: \- To evaluate the efficacy of daily oral doses of 300 ...
Status
Completed
Location
Investigational Site Number 392010
Start Date
2012-11
Trial ID
NCT01692366
Treatments Being Tested
Primary Objective: \- To evaluate the efficacy of daily oral doses of 300 ...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-08
Trial ID
NCT01420770
Treatments Being Tested
This is a Phase 2, multicenter, two-arm, open-label study to evaluate the s...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope and Innovation
Start Date
2021-03-17
Trial ID
NCT04562870
Treatments Being Tested
The purpose of this study is to evaluate the relative bioavailability of fe...
Status
Completed
Location
Syneos Health Clinical Research Services, Llc
Start Date
2021-09-21
Trial ID
NCT05051553
Treatments Being Tested
The purpose of this study is to evaluate the long-term effects of orally ad...
Status
Completed
Location
Investigational Site Number 840103
Start Date
2008-07
Trial ID
NCT00724334
Treatments Being Tested
Primary Objective: * To evaluate the efficacy of daily oral doses of 400 m...
Status
Terminated
Location
Investigational Site Number 840014
Start Date
2011-12-31
Trial ID
NCT01437787
This is an expanded access program (EAP) for eligible participants designed...
Status
Available
Location
Celgene
Start Date
TBD
Trial ID
NCT03723148
Treatments Being Tested
Primary Objective: * To assess the effect of 15-day repeated oral doses of...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2012-06
Trial ID
NCT01585623
Treatments Being Tested